Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data

BACKGROUND: An affordable, highly immunogenic Neisseria meningitidis serogroup A meningococcal conjugate vaccine (PsA–TT) was licensed for use in sub-Saharan Africa in 2009. In 2010, Burkina Faso became the first country to implement a national prevention campaign, vaccinating 11.4 million people ag...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Lancet Infect Dis
Main Authors: Novak, Ryan T, Kambou, Jean Ludovic, Diomandé, Fabien V K, Tarbangdo, Tiga F, Ouédraogo-Traoré, Rasmata, Sangaré, Lassana, Lingani, Clement, Martin, Stacey W, Hatcher, Cynthia, Mayer, Leonard W, LaForce, F Marc, Avokey, Fenella, Djingarey, Mamoudou H, Messonnier, Nancy E, Tiendrébéogo, Sylvestre R, Clark, Thomas A
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4831863/
https://ncbi.nlm.nih.gov/pubmed/22818241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(12)70168-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares